Molecular mapping of the Cromer blood group Cra and Tca epitopes of decay accelerating factor: Toward the use of recombinant antigens in immunohematology

44Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Cromer blood group antigens reside on the complement regulatory protein decay accelerating factor (DAF, CD55). This glycosyl-phosphatidylinositol- anchored glycoprotein is widely distributed, especially among cell types in contact with plasma. Numerous Cromer blood group antigens have been defined using alloantibodies induced by transfusion or pregnancy. However, few pairs of antithetical antigens have been described in this system, presumably because of the rarity of the low-frequency alleles. Analysis of polymerase chain reaction-amplified genomic DNA showed that the Cr(a-) phenotype has a Ala193 → Pro substitution in short consensus repeat 4 (SCR4) of DAF, and the Tc(a-b+) phenotype has a Arg18 → Leu substitution in SCR1 of DAF. The locations of Cra and Tca epitopes were confirmed by analysis of Chinese hamster ovary cell transfectants expressing a Cr(a-) allele-specific transfectant and a chimeric protein containing only SCR1 of DAF, respectively. Overall, these studies further show the usefulness of an approach based on recombinant proteins in mapping blood group antigen epitopes and identifying blood group antibodies.

Cite

CITATION STYLE

APA

Telen, M. J., Rao, N., Udani, M., Thompson, E. S., Kaufman, R. M., & Lublin, D. M. (1994). Molecular mapping of the Cromer blood group Cra and Tca epitopes of decay accelerating factor: Toward the use of recombinant antigens in immunohematology. Blood, 84(9), 3205–3211. https://doi.org/10.1182/blood.v84.9.3205.3205

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free